{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:49:03Z","timestamp":1761630543574},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2010,4,11]],"date-time":"2010-04-11T00:00:00Z","timestamp":1270944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Transplantation"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:p>Shen J, Gill J, Shangguan M, Sampaio MS., Bunnapradist S. Outcomes of renal transplantation in recipients with Wegener\u2019s granulomatosis.\u2028Clin Transplant 2011: 25: 380\u2013387. \u00a9 2010 John Wiley &amp; Sons A\/S.<\/jats:p><jats:p><jats:bold>Abstract:\u2002<\/jats:bold> Wegener\u2019s granulomatosis (WG) is the leading cause of rapidly progressive glomerulonephritis\u2010induced end\u2010stage renal disease (ESRD). In this study, we compared transplant outcomes between recipients with ESRD caused by WG to recipients with ESRD secondary to other causes. Using OPTN\/UNOS data from 1996 to 2007, 919 recipients with WG were identified. Post\u2010transplant outcomes included rates of delayed graft function, acute rejection within one\u2010yr post\u2010transplant, overall and death\u2010censored graft survival, and patient survival and were compared between recipients with ESRD secondary to WG versus ESRD from other causes. Recipients with ESRD because of WG had superior unadjusted and adjusted rates of graft loss, patient death, and functional graft loss (adjusted hazard ratio [HR] 0.711, 0.631, and 0.625 respectively, p\u2003&lt;\u20030.001). When we compared the WG cohort to a non\u2010WG, non\u2010diabetic population, the HR for graft loss was still significant, but patient death and death\u2010censored graft loss were not. Subgroup analysis of recipients aged over 60 confirmed that WG recipients had better unadjusted outcomes. This study supports the notion that renal transplantation is an effective treatment option for patients with ESRD secondary to WG. They fare similarly, if not better, than other patients.<\/jats:p>","DOI":"10.1111\/j.1399-0012.2010.01248.x","type":"journal-article","created":{"date-parts":[[2010,4,12]],"date-time":"2010-04-12T04:01:39Z","timestamp":1271044899000},"page":"380-387","source":"Crossref","is-referenced-by-count":25,"title":["Outcomes of renal transplantation in recipients with Wegener\u2019s granulomatosis"],"prefix":"10.1111","volume":"25","author":[{"given":"Jenny","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagbir","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muyun","family":"Shangguan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo S.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suphamai","family":"Bunnapradist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,8]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.V95842","article-title":"Relapse rate, renal survival, and cancer morbidity in patients with Wegener\u2019s granulomatosis or microscopic polyangiitis with renal involvement","volume":"9","author":"Westman KW","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_10_3_2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.V971258","article-title":"Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody\u2010associated systemic vasculitis","volume":"9","author":"Allen A","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.5.611"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.5.572"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-9-200511010-00005"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-113-9-656"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01904.x"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.1997.tb00560.x"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199705150-00010"},{"key":"e_1_2_10_11_2","first-page":"570","article-title":"Renal transplantation for uncommon diseases. Scientific Advisory Board of the ERA\u2010EDTA Registry. European Renal Association\u2010European Dialysis and Transplant Association","volume":"14","author":"Briggs JD","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_10_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-200301000-00005"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002244"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01988.x"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92716-7"},{"key":"e_1_2_10_16_2","first-page":"839","article-title":"Necrotizing glomerulonephritis associated with antimyeloperoxidase antibodies in a renal transplant recipient with renal failure of unknown origin","volume":"9","author":"Stegeman CA","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_10_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.9.869"},{"key":"e_1_2_10_18_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188694"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188811"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1159\/000188462"},{"key":"e_1_2_10_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(97)90014-7"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199705150-00014"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.29288"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg087"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1999.00666.x"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.02101.x"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01268.x"}],"container-title":["Clinical Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-0012.2010.01248.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-0012.2010.01248.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:38:14Z","timestamp":1697380694000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-0012.2010.01248.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1399-0012.2010.01248.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-0012.2010.01248.x","archive":["Portico"],"relation":{},"ISSN":["0902-0063","1399-0012"],"issn-type":[{"value":"0902-0063","type":"print"},{"value":"1399-0012","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}